Supreme Court Report

Supreme Court of the United States · Official docket →

Dr. Reddy's Laboratories, Ltd., et al. v. Eli Lilly and Company

Paid petition · United States Court of Appeals for the Federal Circuit, No. 18-2128 · judgment August 9, 2019


Certiorari denied · June 15, 2020
Pre-decision estimate: 3% cert probability

Before the decision, well below the 4.1% base rate, with no standout signals pointing toward a grant.

Question presented

Under patent law’s “doctrine of equivalents,” a patent holder can allege infringement even when the defendant does not literally practice every element of a patent claim. But if the patent applicant previously narrowed the claim during prosecution to obtain the patent, the general rule for more than 100 years has been that the patent holder cannot use the doctrine of equivalents in litigation to recapture territory between the broader pre-amendment claim and the narrower post-amendment claim. That rule is known as “prosecution history estoppel.” In Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 535 U.S. 722 (2002), this Court held that prosecution history estoppel does not apply if the patentee can “show that at the time of the amendment one skilled in the art could not reasonably be expected to have drafted a claim that would have literally encompassed the alleged equivalent.” Id. at 741. A patentee can make that showing in different ways, including by demonstrating that the “the rationale underlying the amendment … bear[s] no more than a tangential relation to the equivalent in question.” Id. at 740. The question presented is whether, under Festo’s “tangential” exception to prosecution history estoppel, patent owners may recapture subject matter they could have claimed in prosecution but did not, by arguing that they surrendered more than they needed to during prosecution to address a rejection by the Patent Office.

Counsel of record

For petitioner
John Caviness O'Quinn
Kirkland & Ellis LLP

For respondent
Adam Lawrence Perlman
Latham& Watkins LLP

Case

Conference history
Distributed for 1 conference

Amicus briefs
3 cert-stage

Related
Vide, 19-1058

Linked docket
19A818

Proceedings

  1. Jun 15 2020
    Petition DENIED.
  2. May 26 2020
    DISTRIBUTED for Conference of 6/11/2020.
  3. May 26 2020
    Reply of petitioners Dr. Reddy's Laboratories, Ltd., et al. filed. (Distributed)
  4. May 01 2020
    Motion to delay distribution of the petition for a writ certiorari until May 26, 2020, granted.
  5. Apr 30 2020
    Motion of petitioners to delay distribution of the petition for a writ of certiorari under Rule 15.5 from May 12, 2020 to May 26, 2020, submitted to The Clerk.
  6. Apr 27 2020
    Brief of respondents Eli Lilly & Company in opposition filed. VIDED.
  7. Mar 27 2020
    Brief amicus curiae of Association for Accessible Medicines filed.
  8. Mar 26 2020
    Brief amicus curiae of R Street Institute filed. VIDED.
  9. Mar 26 2020
    Brief amicus curiae of America's Health Insurance Plans filed.
  10. Mar 11 2020
    Motion to extend the time to file a response is granted and the time is extended to and including April 27, 2020.
  11. Mar 10 2020
    Motion to extend the time to file a response from March 27, 2020 to April 27, 2020, submitted to The Clerk.
  12. Feb 24 2020
    Petition for a writ of certiorari filed. (Response due March 27, 2020)
  13. Jan 24 2020
    Application (19A818) granted by The Chief Justice extending the time to file until February 24, 2020.
  14. Jan 22 2020
    Application (19A818) to extend the time to file a petition for a writ of certiorari from February 6, 2020 to February 24, 2020, submitted to The Chief Justice.